相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease
Santosh R. D'Mello
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
KAI1(CD82) is a key molecule to control angiogenesis and switch angiogenic milieu to quiescent state
Jin-Woo Lee et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma
Hiroshi Ito et al.
CANCER RESEARCH (2020)
NRAS palmitoylation and oncogenic fitness
Lucio H. Castilla
BLOOD (2020)
The Glioma Stem Cell Model in the Era of Single-Cell Genomics
Mario L. Suva et al.
CANCER CELL (2020)
Targeting GSK3 and Associated Signaling Pathways Involved in Cancer
Przemyslaw Duda et al.
CELLS (2020)
Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System
Federica Laudisi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Glycogen synthase kinase 3β in tumorigenesis and oncotherapy
Rui He et al.
ONCOLOGY REPORTS (2020)
Glioblastoma cancer stem cell biology: Potential theranostic targets
Farzaneh Sharifzad et al.
DRUG RESISTANCE UPDATES (2019)
Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma
Tomohiro Kitabayashi et al.
SCIENTIFIC REPORTS (2019)
Protein palmitoylation and cancer
Pin-Joe Ko et al.
EMBO REPORTS (2018)
AKT/GSK3β Signaling in Glioblastoma
Ewelina Majewska et al.
NEUROCHEMICAL RESEARCH (2017)
Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1
Jiaxuan Chen et al.
MOLECULAR CARCINOGENESIS (2017)
Inhibition of glycogen synthase kinase 3 beta (GSK3) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity
Shegan Gao et al.
MOLECULAR CARCINOGENESIS (2017)
EZH2 Palmitoylation Mediated by ZDHHC5 in p53-Mutant Glioma Drives Malignant Development and Progression
Xueran Chen et al.
CANCER RESEARCH (2017)
Temozolomide in the Era of Precision Medicine
Anish Thomas et al.
CANCER RESEARCH (2017)
Glycogen synthase kinase-3 is a pivotal mediator of cancer invasion and resistance to therapy
Takahiro Domoto et al.
CANCER SCIENCE (2016)
Inhibition of DHHC20-Mediated EGFR Palmitoylation Creates a Dependence on EGFR Signaling
Kristin B. Runkle et al.
MOLECULAR CELL (2016)
Nuclear GSK3β promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22
Aidong Zhou et al.
NATURE CELL BIOLOGY (2016)
Temozolomide resistance in glioblastoma multiforme
Sang Y. Lee
GENES & DISEASES (2016)
The zDHHC family of S-acyltransferases
Kimon Lemonidis et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2015)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Eleonore Beurel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
THE PHYSIOLOGY OF PROTEIN S-ACYLATION
Luke H. Chamberlain et al.
PHYSIOLOGICAL REVIEWS (2015)
MGMT testing-the challenges for biomarker-based glioma treatment
Wolfgang Wick et al.
NATURE REVIEWS NEUROLOGY (2014)
Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
Eunhee Kim et al.
CANCER CELL (2013)
Glycogen synthase kinase 3 inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling
Ilya V. Pyko et al.
CARCINOGENESIS (2013)
IntOGen-mutations identifies cancer drivers across tumor types
Abel Gonzalez-Perez et al.
NATURE METHODS (2013)
Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
Dagmar Beier et al.
MOLECULAR CANCER (2011)
GSK-3 beta regulates cyclin D1 expression: A new target for chemotherapy
Fumi Takahashi-Yanaga et al.
CELLULAR SIGNALLING (2008)
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
CA Grimes et al.
PROGRESS IN NEUROBIOLOGY (2001)
分享论文
